大熊制药
A mostrar 1–16 de 65 resultados
-
BARUDX Baricitinib
Baricitinib is a selective, reversible JAK1 and JAK2 inhibitor that is taken orally onc…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
POMMADX Pomalidomide
Pomalidomide is a third-generation immunomodulatory agent with multiple anti-myeloma me…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
ISADX Ixazomib 4mg
Ixazomib is an oral, highly selective proteasome inhibitor. It was first approved for m…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
TOFADX Tofacitinib 5mg
Tofacitinib is a JAK inhibitor that effectively inhibits the activity of JAK1 and JAK3,…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
LARODX Larotrectinib
Larotrectinib is a potent, oral, selective tropomyosin receptor kinase (TRK) inhibitor …Escolher opcao This product has multiple variants. The options may be chosen on the product page -
SEMEDX Selumetinib
Selumetinib is indicated for children aged 2 years and older with neurofibromatosis typ…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
FEBUSODX Febuxostat
Febuxostat is a medication used to treat gout, which is primarily caused by high levels…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
RUSODX Ruxolitinib 15mg
In November 2011, ruxolitinib tablets were first approved for marketing in the United S…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
POMMADX Pomalidomide
Pomalidomide is a third-generation immunomodulatory agent with multiple anti-myeloma me…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
OLADX Olaparib
Olaparib is a poly(ADP-polysaccharide) polymerase (PARP) inhibitor that was approved by…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
PRASEDX Pralsetinib
Pralsetinib is an oral, once-daily RET (Rearranged during Transfection) receptor tyrosi…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
AKADX Acalabrutinib 100mg
Acalabrutinib is a targeted therapy. Targeted therapy is the result of years of researc…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
LENADX Lenalidomide 10mg/25mg
Lenalidomide was approved for marketing by the US FDA in December 2005. As a new genera…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
OYSIENDX Osimertinib 80mg
Osimertinib is a third-generation irreversible epidermal growth factor receptor (EGFR) …Escolher opcao This product has multiple variants. The options may be chosen on the product page -
BRATODX Encorafenib
Encorafenib is a small molecule inhibitor of BRAF, a key enzyme in the MAPK signaling p…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
LENVIDX Lenvatinib 4mg
Lenvatinib is a multi-target receptor tyrosine kinase (RTK) inhibitor that inhibits vas…Escolher opcao This product has multiple variants. The options may be chosen on the product page
